Literature DB >> 16120100

Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.

Nancy J Wesensten1, William D S Killgore, Thomas J Balkin.   

Abstract

Stimulants may provide short-term performance and alertness enhancement during sleep loss. Caffeine 600 mg, d-amphetamine 20 mg, and modafinil 400 mg were compared during 85 h of total sleep deprivation to determine the extent to which the three agents restored performance on simple psychomotor tasks, objective alertness and tasks of executive functions. Forty-eight healthy young adults remained awake for 85 h. Performance and alertness tests were administered bi-hourly from 8:00 hours day 2 to 19:00 hours day 5. At 23:50 hours on day 4 (after 64 h awake), subjects ingested placebo, caffeine 600 mg, dextroamphetamine 20 mg, or modafinil 400 mg (n=12 per group). Performance and alertness testing continued, and probe tasks of executive function were administered intermittently until the recovery sleep period (20:00 hours day 5 to 8:00 hours day 5). Bi-hourly postrecovery sleep testing occurred from 10:00 hours to 16:00 hours day 6. All three agents improved psychomotor vigilance speed and objectively measured alertness relative to placebo. Drugs did not affect recovery sleep, and postrecovery sleep performance for all drug groups was at presleep deprivation levels. Effects on executive function tasks were mixed, with improvement on some tasks with caffeine and modafinil, and apparent decrements with dextroamphetamine on others. At the doses tested, caffeine, dextroamphetamine, and modafinil are equally effective for approximately 2-4 h in restoring simple psychomotor performance and objective alertness. The duration of these benefits vary in accordance with the different elimination rates of the drugs. Whether caffeine, dextroamphetamine, and modafinil differentially restore executive functions during sleep deprivation remains unclear.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120100     DOI: 10.1111/j.1365-2869.2005.00468.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  51 in total

1.  Sleepiness is not the inverse of alertness: evidence from four sleep disorder patient groups.

Authors:  Henry J Moller; Gerald M Devins; Jianhua Shen; Colin M Shapiro
Journal:  Exp Brain Res       Date:  2006-04-22       Impact factor: 1.972

2.  A Unified Model of Performance for Predicting the Effects of Sleep and Caffeine.

Authors:  Sridhar Ramakrishnan; Nancy J Wesensten; Gary H Kamimori; James E Moon; Thomas J Balkin; Jaques Reifman
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

4.  Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.

Authors:  Fabien Sauvet; Mégane Erblang; Danielle Gomez-Merino; Arnaud Rabat; Mathias Guillard; Dominique Dubourdieu; Hervé Lefloch; Catherine Drogou; Pascal Van Beers; Clément Bougard; Cyprien Bourrrilhon; Pierrick Arnal; Werner Rein; Franck Mouthon; Francoise Brunner-Ferber; Damien Leger; Yves Dauvilliers; Mounir Chennaoui; Mathieu Charvériat
Journal:  Br J Clin Pharmacol       Date:  2019-09-15       Impact factor: 4.335

5.  Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.

Authors:  E R Samuels; R H Hou; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

6.  Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil.

Authors:  William D S Killgore; Ellen T Kahn-Greene; Nancy L Grugle; Desiree B Killgore; Thomas J Balkin
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

7.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

Review 8.  Deconstructing and reconstructing cognitive performance in sleep deprivation.

Authors:  Melinda L Jackson; Glenn Gunzelmann; Paul Whitney; John M Hinson; Gregory Belenky; Arnaud Rabat; Hans P A Van Dongen
Journal:  Sleep Med Rev       Date:  2012-08-09       Impact factor: 11.609

9.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

Review 10.  Effects of sleep deprivation on neural functioning: an integrative review.

Authors:  T W Boonstra; J F Stins; A Daffertshofer; P J Beek
Journal:  Cell Mol Life Sci       Date:  2007-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.